[DPLO] Diplomat Pharmacy, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Nursing Services

Market Capitalization:

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 12.99 Change: -0.02 (-0.15%)
Ext. hours: Change: 0 (0%)

chart DPLO

Refresh chart

Description: Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. The company stocks, dispenses, and distributes prescriptions for various biotech and specialty pharmaceuticals. It also provides specialty infusion pharmacy, patient care coordination, clinical, compliance and persistency program, patient financial assistance, specialty pharmacy training/consulting, benefits investigation, prior authorization, risk evaluation and medication strategy, retail specialty, and hub services, as well as clinical and administrative support services to hospitals and health systems. The company offers its solutions in range of specialty therapeutic categories, including oncology, immunology, hepatitis, multiple sclerosis, HIV, and infusion therapy. Diplomat Pharmacy, Inc. has seven pharmacy locations in Michigan, Illinois, Florida, California, Connecticut, and Massachusetts. The company was founded in 1975 and is headquartered in Flint, Michigan.

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 15.36% Sales Growth - Q/Q2.09% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA1.09% ROE1.86% ROI
Current Ratio2.09 Quick Ratio1.58 Long Term Debt/Equity Debt Ratio0.66
Gross Margin6.39% Operating Margin0.48% Net Profit Margin0.25% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities152.07 M Cash From Investing Activities-3.91 M Cash From Operating Activities-4.1 M Gross Profit41.14 M
Net Profit2.86 M Operating Profit4.84 M Total Assets544.8 M Total Current Assets444.79 M
Total Current Liabilities212.69 M Total Debt4.7 M Total Liabilities224.46 M Total Revenue624.88 M
Technical Data
High 52 week28.13 Low 52 week14.4 Last close14.83 Last change-0.94%
RSI24.23 Average true range1.35 Beta1.08 Volume808.56 K
Simple moving average 20 days-14.78% Simple moving average 50 days-20.31% Simple moving average 200 days-31.08%
Performance Data
Performance Week-4.51% Performance Month-24.91% Performance Quart-24.91% Performance Half-39.42%
Performance Year-14.38% Performance Year-to-date-26.11% Volatility daily7.6% Volatility weekly16.99%
Volatility monthly34.82% Volatility yearly120.63% Relative Volume189.12% Average Volume928.91 K
New High New Low

News

2019-03-20 20:49:21 | SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Diplomat Pharmacy, Inc. – DPLO

2019-03-20 14:35:00 | Diplomat Pharmacy Looks to Rebuild

2019-03-20 13:16:08 | FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of STMP, DPLO, CTL and BPI

2019-03-20 10:44:00 | Bronstein, Gewirtz & Grossman, LLC Class Action Reminder Vanda Pharmaceuticals Inc. VNDA, Stamps.com Inc. STMP & Diplomat Pharmacy, Inc. DPLO

2019-03-20 09:37:20 | CLASS ACTION UPDATE for TYME, KHC, DPLO and CTL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

2019-03-19 21:00:00 | Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Health Insurance, Conagra, Kraft Heinz, and Diplomat and Encourages Investors to Contact the Firm

2019-03-19 19:00:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Diplomat Pharmacy, Inc. of Class Action Lawsuit and Upcoming Deadline – DPLO

2019-03-19 18:07:00 | LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Diplomat Pharmacy, Inc. To Contact The Firm

2019-03-19 12:13:11 | SHAREHOLDER ALERT: AVP DPLO VNDA CTL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

2019-03-19 10:44:00 | Class Action Reminder Vanda Pharmaceuticals Inc. VNDA, Stamps.com Inc. STMP & Diplomat Pharmacy, Inc. DPLO - Bronstein, Gewirtz & Grossman, LLC

2019-03-18 15:18:17 | Analysts React To Diplomat Pharmacy's Q4 Earnings, Concerning Guidance

2019-03-18 10:24:07 | Diplomat Pharmacy, Inc. -- Moody's: Diplomat Pharmacy's weakening performance is credit negative

2019-03-17 10:07:00 | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of DPLO, SYNH, BPI and CNDT

2019-03-17 09:30:00 | INVESTOR ALERT: Rosen Law Firm Reminds Diplomat Pharmacy, Inc. Investors of Important Deadline in Securities Class Action Filed by the Firm - DPLO

2019-03-17 09:00:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Diplomat Pharmacy, Inc. of Class Action Lawsuit and Upcoming Deadline – DPLO

2019-03-15 23:13:18 | Diplomat Pharmacy Inc DPLO Q4 2018 Earnings Conference Call Transcript

2019-03-15 22:50:00 | DIPLOMAT PHARMACY SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Diplomat Pharmacy, Inc. - DPLO

2019-03-15 17:48:00 | Here's Why Diplomat Pharmacy Stock Fell 13.6% Today

2019-03-15 17:42:55 | Edited Transcript of DPLO earnings conference call or presentation 15-Mar-19 12:00pm GMT

2019-03-15 16:34:00 | LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Diplomat Pharmacy, Inc. To Contact The Firm

2019-03-15 15:35:00 | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ASTE, TAP and DPLO

2019-03-15 14:00:00 | Johnson Fistel, LLP Files Class Action Suit against Diplomat Pharmacy, Inc.

2019-03-15 11:46:52 | FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of TYME, DPLO, CVS and SYNH

2019-03-15 07:49:25 | Diplomat Pharmaceuticals: 4Q Earnings Snapshot

2019-03-15 07:30:00 | Diplomat Announces 4th Quarter and 2018 Year End Financial Results; Provides Revised 2019 Guidance

2019-03-15 07:25:00 | Diplomat Appoints Daniel Davison as Chief Financial Officer

2019-03-14 21:26:22 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Diplomat Pharmacy, Inc. of Class Action Lawsuit and Upcoming Deadline – DPLO

2019-03-14 15:00:00 | DPLO Diplomat Pharmacy, Inc. - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action & Deadline: April 25, 2019

2019-03-14 13:32:00 | FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ARLO, DPLO and SYNH

2019-03-14 10:16:00 | AMRN, CAG & DPLO Bronstein, Gewirtz & Grossman, LLC Class Action Update

2019-03-13 17:19:33 | SHAREHOLDER ALERT: DPLO CAG CVS CTL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

2019-03-13 16:30:00 | SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Diplomat Pharmacy, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-03-13 16:30:00 | Diplomat Announces Details of Rescheduled 2018 Results Conference Call

2019-03-13 11:30:00 | CLASS ACTION UPDATE for ASTE, DPLO and CNDT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

2019-03-13 10:16:00 | AMRN, CAG & DPLO Bronstein, Gewirtz & Grossman, LLC Update

2019-03-12 15:34:18 | DPLO DEADLINE ALERT: Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against Diplomat Pharmacy, Inc.– DPLO

2019-03-12 15:20:00 | SHAREHOLDER ALERT: VALE DPLO BPI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

2019-03-12 10:14:00 | Class Action - AMRN, CAG & DPLO Bronstein, Gewirtz & Grossman, LLC

2019-03-11 18:48:52 | INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Diplomat Pharmacy, Inc. Investors

2019-03-11 18:02:00 | LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Diplomat Pharmacy, Inc. To Contact The Firm

2019-03-11 17:50:13 | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of STMP, DPLO, BPI and USX

2019-03-11 16:45:12 | INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Diplomat Pharmacy, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-03-10 10:01:00 | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of UXIN, BRS and DPLO

2019-03-10 09:10:00 | DPLO Alert: Johnson Fistel, LLP Reminds Investors of Deadline in the Class Action Lawsuit Against Diplomat Pharmacy, Inc.

2019-03-08 22:50:00 | DIPLOMAT PHARMACY SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Diplomat Pharmacy, Inc. - DPLO

2019-03-08 22:02:00 | IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Diplomat Pharmacy, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-03-08 16:05:00 | CLASS ACTION UPDATE for SPB, VALE and DPLO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

2019-03-08 12:00:00 | DPLO Diplomat Pharmacy, Inc. - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action & Deadline: April 25, 2019

2019-03-08 11:55:00 | SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Diplomat Pharmacy, Inc. - DPLO

2019-03-08 09:15:00 | SHAREHOLDER ALERT: SVXY MHLD TAP DPLO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines